Kintor Pharmaceutical Files Director List with HKEX

Reuters12-11
<a href="https://laohu8.com/S/KNTPF">Kintor Pharmaceutical</a> Files Director List with HKEX

Kintor Pharmaceutical Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board comprises Executive Directors Dr. Youzhi Tong and Dr. Xiang Ni; Non-executive Directors Mr. Yunfei Chen and Ms. Geqi Wei; and Independent Non-executive Directors Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung, and Prof. Liang Tong. Dr. Michael Min Xu chairs both the Remuneration and Nomination Committees and serves as a member of the Audit Committee. Mr. Wallace Wai Yim Yeung chairs the Audit Committee and is a member of the Nomination Committee. Prof. Liang Tong is a member of both the Audit and Remuneration Committees. Dr. Youzhi Tong and Ms. Geqi Wei are members of the Remuneration and Nomination Committees, respectively.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kintor Pharmaceutical Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952292), on December 11, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment